AI assistant
TRANSENSE TECHNOLOGIES PLC Director's Dealing 2021
7985_dirs_2021-06-23_8c3a5723-6221-419d-b5a1-95970561cb79.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 7681C
Transense Technologies PLC
23 June 2021
23 June 2021
Transense Technologies plc
("Transense" or the "Company")
Director/PDMR shareholding
Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, has been notified that Nigel Rogers, Executive Chairman of the Company, yesterday undertook a sale and repurchase of 25,000 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") to migrate part of his current shareholding into his own ISA. Accordingly, Nigel Rogers' total beneficial shareholding in the Company remains unchanged at 200,000 Ordinary shares, which represents 1.23% of the issued share capital.
Further details are provided in the forms below in accordance with the requirements of the UK Market Abuse Regulation.
For further information please visit www.transense.com or contact:
| Transense Technologies plc Nigel Rogers (Executive Chairman) Melvyn Segal (CFO) |
Via Walbrook PR |
| Allenby Capital (Nominated Adviser and Broker) Jeremy Porter / George Payne (Corporate Finance) Tony Quirke (Sales and Corporate Broking) |
Tel: +44 (0)20 3328 5656 |
| Walbrook PR Tom Cooper/Nick Rome/Nicholas Johnson |
Tel: +44 (0)20 7933 8780 [email protected] |
Notes to Editors:
Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense'sTyre Pressure Monitoring System, recently licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include automotive, aerospace, industrial, green energy, rail and marine.
The Company's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.
The Company has a significant licensing agreement with General Electric Company ("GE") for the use of patented, wireless, passive SAW technology in GE Aviation's T901-GE-900 engine for the U.S. Army Engineering and Manufacturing Development ("EMD") phase of the Improved Turbine Engine Program ("ITEP"), which is the programme to replace more than 6,000 engines in its current fleet of Boeing AH-64 Apache and Sikorsky UH60 Black Hawk helicopters, expected to commence in 2024 reaching full volume in 2026.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.
For further information please contact [email protected]
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Nigel Rogers |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Chairman |
| b) | Initial notification /Amendment | Initial |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Transense Technologies plc |
| b) | LEI | 2138005N52J6KKQ3EY67 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of 10 pence each |
| Identification code | GB00BDHDTH21 | |
| b) | Nature of the transaction | Sale of Ordinary Shares |
| c) | Price and volume | Price: 75 pence per share Volume: 25,000 |
| d) | Aggregated information | |
| - Aggregated volume | As above | |
| - Price | ||
| e) | Date of the transaction | 22 June 2021 |
| f) | Place of the transaction | London Stock Exchange, AIM |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Nigel Rogers |
| 2 | Reason for the notification | |
| a) | Position/status | Executive Chairman |
| b) | Initial notification /Amendment | Initial |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Transense Technologies plc |
| b) | LEI | 2138005N52J6KKQ3EY67 |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of 10 pence each |
| Identification code | GB00BDHDTH21 | |
| b) | Nature of the transaction | Purchase of Ordinary Shares |
| c) | Price and volume | Price: 75.1 pence per share Volume: 25,000 |
| d) | Aggregated information | |
| - Aggregated volume | As above | |
| - Price | ||
| e) | Date of the transaction | 22 June 2021 |
| f) | Place of the transaction | London Stock Exchange, AIM |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFETRLIFFIL